Literature DB >> 26016897

The Possible Interaction between Receptor Activator of Nuclear Factor Kappa-B Ligand Expressed by Extramammary Paget Cells and its Ligand on Dermal Macrophages.

Yumi Kambayashi1, Taku Fujimura2, Sadanori Furudate1, Masayuki Asano1, Aya Kakizaki1, Setsuya Aiba1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26016897     DOI： 10.1038/jid.2015.199

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  12 in total

1.  Clinicopathological study of invasive extramammary Paget's disease: subgroup comparison according to invasion depth.

Authors:  T Shiomi; T Noguchi; H Nakayama; Y Yoshida; O Yamamoto; N Hayashi; K Ohara
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-02-25       Impact factor: 6.166

2.  FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are associated with recurrence.

Authors:  Joshua Z Press; Kimberly H Allison; Rochelle Garcia; Elise N Everett; Ellen Pizer; Ron E Swensen; Hisham K Tamimi; Heidi J Gray; William A Peters; Barbara A Goff
Journal:  Gynecol Oncol       Date:  2011-02       Impact factor: 5.482

Review 3.  RANKL inhibition: a promising novel strategy for breast cancer treatment.

Authors:  Eva González-Suárez
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

4.  Contrary view: the breast is not an organ per se, but a distinctive region of skin and subcutaneous tissue.

Authors:  A Bernard Ackerman; Galen Kessler; Tibor Gyorfi; Hui C Tsou; Geoffrey J Gottlieb
Journal:  Am J Dermatopathol       Date:  2007-04       Impact factor: 1.533

5.  Comparison of Foxp3+ regulatory T cells and CD163+ macrophages in invasive and non-invasive extramammary Paget's disease.

Authors:  Taku Fujimura; Yumi Kambayashi; Takanori Hidaka; Akira Hashimoto; Takahiro Haga; Setsuya Aiba
Journal:  Acta Derm Venereol       Date:  2012-11       Impact factor: 4.437

6.  Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells.

Authors:  Karin Loser; Annette Mehling; Stefanie Loeser; Jenny Apelt; Annegret Kuhn; Stephan Grabbe; Thomas Schwarz; Josef M Penninger; Stefan Beissert
Journal:  Nat Med       Date:  2006-12-03       Impact factor: 53.440

7.  MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL.

Authors:  Conor C Lynch; Atsuya Hikosaka; Heath B Acuff; Michelle D Martin; Noriyasu Kawai; Rakesh K Singh; Tracy C Vargo-Gogola; Jennifer L Begtrup; Todd E Peterson; Barbara Fingleton; Tomoyuki Shirai; Lynn M Matrisian; Mitsuru Futakuchi
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

8.  Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse.

Authors:  Gaynor J Bates; Stephen B Fox; Cheng Han; Russell D Leek; José F Garcia; Adrian L Harris; Alison H Banham
Journal:  J Clin Oncol       Date:  2006-12-01       Impact factor: 44.544

9.  The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.

Authors:  Catharina Medrek; Fredrik Pontén; Karin Jirström; Karin Leandersson
Journal:  BMC Cancer       Date:  2012-07-23       Impact factor: 4.430

10.  Potential use of bisphosphonates in invasive extramammary Paget's disease: an immunohistochemical Investigation.

Authors:  Taku Fujimura; Sadanori Furudate; Yumi Kambayashi; Setsuya Aiba
Journal:  Clin Dev Immunol       Date:  2013-03-31
View more
  12 in total

1.  Receptor Activator of NF-κB Ligand Promotes the Production of CCL17 from RANK+ M2 Macrophages.

Authors:  Taku Fujimura; Yumi Kambayashi; Sadanori Furudate; Masayuki Asano; Aya Kakizaki; Setsuya Aiba
Journal:  J Invest Dermatol       Date:  2015-06-08       Impact factor: 8.551

Review 2.  RANKL biology.

Authors:  Noriko Takegahara; Hyunsoo Kim; Yongwon Choi
Journal:  Bone       Date:  2022-02-16       Impact factor: 4.626

Review 3.  RANK-RANKL signalling in cancer.

Authors:  Nathalie Renema; Benjamin Navet; Marie-Françoise Heymann; Frédéric Lezot; Dominique Heymann
Journal:  Biosci Rep       Date:  2016-08-05       Impact factor: 3.840

4.  Successful Treatment of Advanced Primary Cutaneous Apocrine Carcinoma on the Scrotum with Systemic Chemotherapy and Radiotherapy Followed by Denosumab.

Authors:  Sadanori Furudate; Taku Fujimura; Akira Tsukada; Yota Sato; Takanori Hidaka; Kayo Tanita; Yumi Kambayashi; Takahiro Haga; Akira Hashimoto; Setsuya Aiba
Journal:  Case Rep Oncol       Date:  2017-01-16

Review 5.  Metastatic Extramammary Paget's Disease: Pathogenesis and Novel Therapeutic Approach.

Authors:  Keitaro Fukuda; Takeru Funakoshi
Journal:  Front Oncol       Date:  2018-02-16       Impact factor: 6.244

6.  Dual targeting of RANKL and PD-1 with a bispecific antibody improves anti-tumor immunity.

Authors:  William C Dougall; Amelia Roman Aguilera; Mark J Smyth
Journal:  Clin Transl Immunology       Date:  2019-09-27

7.  Successful Treatment of Multiple Metastatic Melanoma with Nivolumab, Ipilimumab plus Denosumab Combined Therapy.

Authors:  Saaya Yoshida; Taku Fujimura; Yumi Kambayashi; Ryo Amagai; Akira Hashimoto; Setsuya Aiba
Journal:  Case Rep Oncol       Date:  2019-10-30

8.  Merkel Cell Carcinoma with Spontaneous Regression: A Case Report and Immunohistochemical Study.

Authors:  Hitoshi Terui; Taku Fujimura; Aya Kakizaki; Sadanori Furudate; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2016-02-24

9.  RANKL-Expressing Ectopic Extramammary Paget's Disease on the Lower Abdomen.

Authors:  Akiko Hagiwara-Takita; Taku Fujimura; Aya Kakizaki; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2016-06-06

Review 10.  Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer.

Authors:  Taku Fujimura; Yumi Kambayashi; Yasuhiro Fujisawa; Takanori Hidaka; Setsuya Aiba
Journal:  Front Oncol       Date:  2018-01-23       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.